The historic rise of Viagra has firmly established as a example of pharmaceutical success, however its future within the broader market now raises questions about future gains. Copycat versions are eroding exclusivity , leading to anxieties that supporting companies significantly dependent to Viagra's previous standing could be a dangerous strategy